PHOTOPORATION OF NK92 CELLS WITH BIODEGRADABLE POLYDOPAMINE NANOSENSITIZERS AS A PROMISING STRATEGY FOR THE GENERATION OF CAR-NK CELL THERAPIES.

被引：0
|
作者：
Hinnekens, C. [1 ]
Harizaj, A. [1 ]
Goemaere, I. [1 ]
Berdecka, D. [1 ]
De Smedt, S. [1 ]
Vandekerckhove, B. [2 ]
Fraire, J. [1 ]
Braeckmans, K. [1 ]
机构：
[1] UGent, Lab Gen Biochem Phys Pharm, Ghent, Belgium
[2] Univ Ghent, Dept Diagnost Sci, Ghent, Belgium
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P060
引用
收藏
页码：A34 / A35
页数：2
相关论文
共 50 条
  • [1] PHOTOPORATION OF NK-92MI CELLS WITH BIODEGRADABLE POLYDOPAMINE NANOSENSITIZERS AS A PROMISING STRATEGY FOR THE GENERATION OF CAR-NK CELL THERAPIES
    Hinnekens, C.
    Harizaj, A.
    Berdecka, D.
    De Smedt, S. C.
    Vandekerckhove, B.
    Braeckmans, K.
    Fraire, J.
    CYTOTHERAPY, 2024, 26 (06) : S170 - S170
  • [2] Photoporation of NK-92MI cells with biodegradable polydopamine nanosensitizers as a promising strategy for the generation of engineered NK cell therapies
    Hinnekens, Charlotte
    Harizaj, Aranit
    Berdecka, Dominika
    Aernout, Ilke
    Shariati, Molood
    Peeters, Stefanie
    Lion, Eva
    De Smedt, Stefaan C.
    Vandekerckhove, Bart
    Braeckmans, Kevin
    Fraire, Juan C.
    Applied Materials Today, 2024, 40
  • [3] TOWARDS ENGINEERED NK CELL THERAPY: mRNA TRANSFECTION OF NK92 CELLS BY PHOTOPORATION WITH BIODEGRADABLE POLYDOPAMINE NANOSENSITIZERS
    Hinnekens, C.
    Harizaj, A.
    Goemare, I.
    De Smedt, S. C.
    Vandekerckhove, B.
    Fraire, J.
    Braeckmans, K.
    CYTOTHERAPY, 2023, 25 (06) : S228 - S228
  • [4] Next-generation cell therapies: the emerging role of CAR-NK cells
    Basar, Rafet
    Daher, May
    Rezvani, Katayoun
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 570 - 578
  • [5] Next-generation cell therapies: the emerging role of CAR-NK cells
    Basar, Rafet
    Daher, May
    Rezvani, Katayoun
    BLOOD ADVANCES, 2020, 4 (22) : 5868 - 5876
  • [6] CAR-NK cells: A promising cellular immunotherapy for cancer
    Xie, Guozhu
    Dong, Han
    Liang, Yong
    Ham, James Dongjoo
    Rizwan, Romee
    Chen, Jianzhu
    EBIOMEDICINE, 2020, 59
  • [7] CAR-NK cell in cancer immunotherapy; A promising frontier
    Marofi, Faroogh
    Abdul-Rasheed, Omar F.
    Rahman, Heshu Sulaiman
    Budi, Hendrik Setia
    Jalil, Abduladheem Turki
    Yumashev, Alexei Valerievich
    Hassanzadeh, Ali
    Yazdanifar, Mahboubeh
    Motavalli, Roza
    Chartrand, Max Stanley
    Ahmadi, Majid
    Cid-Arreguid, Angel
    Jarahian, Mostafa
    CANCER SCIENCE, 2021, 112 (09) : 3427 - 3436
  • [8] CAR-NK cells: a promising cellular immunotherapy in lymphoma
    Khanmohammadi, Shaghayegh
    Rezaei, Nima
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 37 - 47
  • [9] CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
    Sabbah, Mohamad
    Jondreville, Ludovic
    Lacan, Claire
    Norol, Francoise
    Vieillard, Vincent
    Roos-Weil, Damien
    Nguyen, Stephanie
    CANCERS, 2022, 14 (15)
  • [10] Current Perspectives on "Off-The-Shelf" Allogeneic NK and CAR-NK Cell Therapies
    Heipertz, Erica L.
    Zynda, Evan R.
    Stav-Noraas, Tor Espen
    Hungler, Andrew D.
    Boucher, Shayne E.
    Kaur, Navjot
    Vemuri, Mohan C.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345